Furthermore, our previous study showed that PD-L1 expression level was associated with the frequency of primary resistance to EGFR-TKIs in treatment naïve advanced lung adenocarcinoma patients with EGFR mutation23. Here, EGFR is linked to lung adenocarcinoma.